Biotechnology
45+ years of experience empowering biotechnology innovation
Why Cooley
-
#1
VC Firm for Pharma + Biotech Deals – PitchBook, 2024
-
1,700+
private and public biotechnology clients
-
50%
of the companies on the NASDAQ Biotechnology Index are represented by Cooley
-
Service capabilities built specifically for biotechnology and life sciences companies, spanning corporate, litigation, regulatory and intellectual property matters
-
Industry-leading team that includes former biotech researchers, pharmaceutical marketing professionals, business consultants and in-house counsel at life sciences companies
-
Unmatched access to the largest and most influential network of strategic investors in the biotech sector
Life Sciences & Healthcare Innovation Hub
Comprehensive resource for key stakeholders across the global life sciences and healthcare industry
Cooley Rx
A virtual series focused on the life sciences and healthcare sectors
Group contacts
